- Recent Funding
- Investors
- California Institute for Regenerative Medicine
California Institute for Regenerative Medicine portfolio
California Institute for Regenerative Medicine has 2 portfolio companies on record at Recent Funding.
About this page
By category, its portfolio leans toward Health and bio (2).
What California Institute for Regenerative Medicine invests in
- Health and bio · 2 · 100%
California Institute for Regenerative Medicine portfolio companies
EEpicrispr Biotechnologiesbacker
NNavega Therapeuticsbacker
| Company | Round with California Institute for Regenerative Medicine | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
backer | $158M | Aug 11, 2026 Series B+ |
Health and bio |
backer | undisclosed | Nov 26, 2024 Series A |
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Portfolio companies are the companies on Recent Funding with a round that lists California Institute for Regenerative Medicine, which is a subset of its real portfolio. API: /api/v1/investors/california-institute-for-regenerative-medicine (get a free API key). More: the most active VC firms and new venture capital funds.